Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Pulmonology · Idiopathic and Heritable Pulmonary Arterial Hypertension

Biology & Genetics: How IPAH/HPAH Works in Your Body

At a Glance

Idiopathic and Heritable Pulmonary Arterial Hypertension (IPAH/HPAH) are driven by vascular remodeling, a process where lung arteries grow thick and narrow. This is often caused by genetic mutations, such as in the BMPR2 gene, which disrupt the normal signals that control cell growth.

While most people think of “high blood pressure” as a condition affecting the whole body, Pulmonary Arterial Hypertension (PAH) is a specific biological process happening only in the “pipes” that connect your heart to your lungs. Understanding the biology of this disease helps explain why specialized treatments are so important.

It’s Not Just Pressure—It’s “Remodeling”

In a healthy body, the pulmonary arteries are thin, flexible tubes that allow blood to flow easily. In PAH, these vessels undergo a process called vascular remodeling [1]. Think of this like a pipe that isn’t just clogged with debris, but a pipe where the metal walls themselves are growing thicker and thicker until there is almost no room for water to pass through.

This thickening happens because the cells that line your arteries—the endothelial cells and smooth muscle cells—begin to multiply uncontrollably [1]. As the walls get thick and stiff, the right side of your heart has to pump much harder to push blood through, which eventually causes the heart muscle to tire out.

The Role of Genetics: The “Stop” and “Go” Signals

Your body uses signals to tell cells when to grow and when to stop. In many cases of PAH, these signals get out of balance.

  • BMPR2: The “Stop” Signal. The BMPR2 gene is the most common gene linked to PAH [2]. Normally, this gene acts like a “stop” signal, preventing the cells in your lung’s arteries from over-multiplying. When this gene is mutated, that stop signal is lost [3][4].
  • TGF-Beta: The “Go” Signal. While the stop signal (BMPR2) is broken, the “go” signal (a protein called TGF-beta) becomes too strong. This creates a massive imbalance that drives the cells to grow and the vessels to thicken [3][1].

Emerging Genes: SOX17 and TBX4

While BMPR2 is the most famous gene in PAH, researchers have found others that play unique roles:

  • SOX17: This gene is crucial for the health of the vessel lining. When it doesn’t work correctly, the vessels can’t repair themselves properly and become “leaky” or dysfunctional [5][6].
  • TBX4: This gene is often linked to the structural development of the lungs and bones. People with TBX4 mutations might have had lung issues since childhood or even unusual skeletal features, like missing kneecaps [7][8].

Idiopathic vs. Heritable: What’s the Difference?

The terms “Idiopathic” and “Heritable” describe how the disease started:

  • Idiopathic (IPAH): This means the cause is unknown. You do not have a known family history or a detectable genetic mutation [9].
  • Heritable (HPAH): This means the disease is linked to a genetic mutation you were born with, even if no one else in your family has been diagnosed yet [10].

Patients with HPAH (especially the BMPR2 type) often develop symptoms at a younger age and may have higher lung pressures at the time of diagnosis compared to those with the idiopathic form [11][12].

Genetic Counseling: Protecting Your Family

Because PAH can be genetic, testing is now considered an essential part of the medical check-up [10]. If a mutation is found, your close relatives (parents, siblings, and children) can choose to have cascade testing. This allows them to know if they carry the gene. While not everyone with the gene will develop PAH, knowing they have it allows for regular screening so the disease can be caught and treated at the very earliest stage [13][10].

Common questions in this guide

What is the difference between IPAH and HPAH?
Idiopathic Pulmonary Arterial Hypertension (IPAH) has no known cause or detectable genetic mutation. Heritable Pulmonary Arterial Hypertension (HPAH) is linked to a specific genetic mutation you were born with, even if no other family members have been diagnosed.
What does vascular remodeling mean in pulmonary hypertension?
Vascular remodeling is a process where the walls of the pulmonary arteries grow excessively thick and stiff due to cells multiplying uncontrollably. This narrows the blood vessels, making it much harder for the right side of the heart to pump blood through the lungs.
What role does the BMPR2 gene play in pulmonary hypertension?
The BMPR2 gene normally acts as a biological stop signal that keeps the cells in your lung arteries from over-multiplying. When this gene is mutated, the stop signal is lost, leading to thickened, narrowed arteries.
Should my family members be tested if I have a PAH genetic mutation?
If you have a known genetic mutation linked to PAH, your close relatives may consider cascade genetic testing. This helps identify if they carry the same gene, allowing for regular screening and early detection before severe symptoms appear.
Can pulmonary hypertension genes cause other physical symptoms?
Yes, some genetic mutations associated with pulmonary hypertension affect structural development in the body. For example, TBX4 mutations are sometimes linked to unusual skeletal features like small or missing kneecaps.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Have I been tested for the BMPR2, SOX17, and TBX4 genes, and what were the results?
  2. 2.If I have a genetic mutation, what does that mean for my children or siblings? Should they be referred to a genetic counselor?
  3. 3.Does my genetic profile make me a candidate for 'disease-modifying' therapies like sotatercept that target these specific biological pathways?
  4. 4.Based on my age and my genetic results, is my disease likely to behave differently than 'typical' cases of IPAH?
  5. 5.Are there any specific skeletal or developmental signs you’ve noticed that might link my PAH to a specific gene like TBX4?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (13)
  1. 1

    THBS4 Regulates Pulmonary Hypertension via TGF-β/SMAD2 Signaling.

    Zeng J, Li D, Wang J, et al.

    Hypertension (Dallas, Tex. : 1979) 2026; (83(6)):e25968 doi:10.1161/HYPERTENSIONAHA.125.25968.

    PMID: 41873540
  2. 2

    Germline BMP9 mutation causes idiopathic pulmonary arterial hypertension.

    Wang XJ, Lian TY, Jiang X, et al.

    The European respiratory journal 2019; (53(3)) doi:10.1183/13993003.01609-2018.

    PMID: 30578397
  3. 3

    Sotatercept and pulmonary arterial hypertension.

    Tan Y, Chen Y, Li J

    Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 2024; (49(9)):1503-1508 doi:10.11817/j.issn.1672-7347.2024.240093.

    PMID: 39931780
  4. 4

    CircGSAP alleviates pulmonary microvascular endothelial cells dysfunction in pulmonary hypertension via regulating miR-27a-3p/BMPR2 axis.

    Sun Y, Jiang R, Hu X, et al.

    Respiratory research 2022; (23(1)):322 doi:10.1186/s12931-022-02248-7.

    PMID: 36403044
  5. 5

    SOX17-Associated Pulmonary Hypertension in Children: A Distinct Developmental and Clinical Syndrome.

    Mullen MP, Ivy DD, Varghese NP, et al.

    The Journal of pediatrics 2025; (278()):114422 doi:10.1016/j.jpeds.2024.114422.

    PMID: 39603521
  6. 6

    E2F1 Mediates SOX17 Deficiency-Induced Pulmonary Hypertension.

    Yi D, Liu B, Ding H, et al.

    Hypertension (Dallas, Tex. : 1979) 2023; (80(11)):2357-2371 doi:10.1161/HYPERTENSIONAHA.123.21241.

    PMID: 37737027
  7. 7

    TBX4 variants and pulmonary diseases: getting out of the 'Box'.

    Haarman MG, Kerstjens-Frederikse WS, Berger RMF

    Current opinion in pulmonary medicine 2020; (26(3)):277-284 doi:10.1097/MCP.0000000000000678.

    PMID: 32195678
  8. 8

    Long-Term Effect of TBX4 Germline Mutation on Pulmonary Clinico-Histopathologic Phenotype.

    Doughty ES, Norvik C, Levin A, et al.

    Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society 2024; (27(1)):83-89 doi:10.1177/10935266231199933.

    PMID: 37801629
  9. 9

    A Retrospective Population-Based Survival Study of Idiopathic Pulmonary Arterial Hypertension in Korea.

    Jang SY, Kim EK, Huh J, et al.

    Journal of Korean medical science 2022; (37(10)):e80 doi:10.3346/jkms.2022.37.e80.

    PMID: 35289139
  10. 10

    Clinical characteristics and prognosis analysis of idiopathic and hereditary pulmonary hypertension patients with ACVRL1 gene mutations.

    Zhang X, Zhang C, Li Q, et al.

    Pulmonary circulation 2021; (11(4)):20458940211044577 doi:10.1177/20458940211044577.

    PMID: 34966542
  11. 11

    Whole Exome Sequencing of Patients With Heritable and Idiopathic Pulmonary Arterial Hypertension in Central Taiwan.

    Liang KW, Chang SK, Chen YW, et al.

    Frontiers in cardiovascular medicine 2022; (9()):911649 doi:10.3389/fcvm.2022.911649.

    PMID: 35811711
  12. 12

    Prevalence and clinical features of bone morphogenetic protein receptor type 2 mutation in Korean idiopathic pulmonary arterial hypertension patients: The PILGRIM explorative cohort.

    Jang AY, Kim BG, Kwon S, et al.

    PloS one 2020; (15(9)):e0238698 doi:10.1371/journal.pone.0238698.

    PMID: 32966279
  13. 13

    Heritable pulmonary hypertension: from bench to bedside.

    Girerd B, Weatherald J, Montani D, Humbert M

    European respiratory review : an official journal of the European Respiratory Society 2017; (26(145)) doi:10.1183/16000617.0037-2017.

    PMID: 28877973

This page explains the biology and genetics of IPAH and HPAH for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or genetic counseling.

Get notified when new evidence is published on Idiopathic/heritable pulmonary arterial hypertension.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.